Total Funding
40
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 40 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
117295
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization.
Acquired by 
Adare Pharmaceuticals
Puneet Sapra: Chief Financial OfficerPast Role: Johnson & Johnson, Team Member
Song Li: CEOPast Role: Frontage Laboratories, Co-Founder, Chairman & Chief Executive officer
About the Company
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient
(HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.

